Biodexa Pharmaceuticals
BDRX----
Biodexa Pharmaceuticals (BDRX)
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Biodexa Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jun 29, 2026Price forecast
$9.96503.79%
Forecast & Rating-
0analysts
News
- Global Report · 11 hours ago
Biotech Regulatory Clearances and Edge AI Pivots Prompt Capital Reallocation Across US Equities
- Global Report · 1 day ago, 04:17 AM
Inside the Biotech Sector's Recent Clinical Catalyst Wave
- Global Report · 1 day ago, 04:14 AM
monday.com's AI Pivot and Tron's Token Buildup Highlight Small-Cap Realignments
- Global Report · 2 days ago, 04:13 AM
The 2026 Biotech Divide: When Generative Biology Meets the FDA Wall
- benzinga_article · Jul 22 at 04:05 PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
- PUBT · Jul 9 at 03:16 PM
Biodexa seeks shareholder approval to adopt new articles of association for E deferred shares
